BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14119457)

  • 1. [RESULTS OF TYPING MYCOBACTERIUM TUBERCULOSIS WITH A BIOLOGICAL METHOD].
    MULAK K; BIELANSKA A
    Gruzlica (1926); 1963 Jun; 31():707-10. PubMed ID: 14119457
    [No Abstract]   [Full Text] [Related]  

  • 2. THE IMMUNOGENICITY OF BCG (PHIPPS) AND ITS ISONIAZID-RESISTANT MUTANT IN GUINEA PIGS SIMULTANEOUSLY VACCINATED, INFECTED, AND TREATED.
    DWORSKI M
    Am Rev Respir Dis; 1964 Jul; 90():97-104. PubMed ID: 14180060
    [No Abstract]   [Full Text] [Related]  

  • 3. [EXPERIENCES WITH SOME METHODS OF TYPING MYCOBACTERIUM BOVIS].
    GRIGELOVA R
    Cesk Epidemiol Mikrobiol Imunol; 1964 Jan; 13():28-34. PubMed ID: 14109643
    [No Abstract]   [Full Text] [Related]  

  • 4. OBSERVATIONS ON NIACIN TEST IN IDENTIFICATION OF HUMAN TYPE OF TUBERCLE BACILLI.
    MAHAPATRA B; GUPTA SP
    Indian J Med Res; 1963 Nov; 51():993-6. PubMed ID: 14094141
    [No Abstract]   [Full Text] [Related]  

  • 5. PULMONARY TUBERCULOSIS IN GUINEA PIGS BY TRANS-TRACHEAL INOCULATION.
    LORIAN V; ZANON U
    Acta Tuberc Pneumol Scand; 1964; 44():76-82. PubMed ID: 14159899
    [No Abstract]   [Full Text] [Related]  

  • 6. THE IN VIRTO ACTIVITY OF 4,4'-DIAMINODIPHENYL SULFONE AGAINST VARIOUS ACID-FAST MICROORGANISMS.
    KARLSON AG
    Int J Lepr; 1963; 31():183-7. PubMed ID: 14086703
    [No Abstract]   [Full Text] [Related]  

  • 7. THE VIRULENCE IN THE GUINEA-PIG OF TUBERCLE BACILLI FROM PATIENTS WITH PULMONARY TUBERCULOSIS IN HONG KONG.
    DICKINSON JM; LEFFORD MJ; LLOYD J; MITCHISON DA
    Tubercle; 1963 Dec; 44():446-51. PubMed ID: 14101325
    [No Abstract]   [Full Text] [Related]  

  • 8. [ANTIMYCOBACTERIAL ACTIVITY OF ISOXYL. II. EXPERIMENTS WITH GUINEA PIGS AND RABBITS].
    URBANCIK R; TRNKA L; KRUML J; POLENSKA H
    Pathol Microbiol (Basel); 1964; 27():79-87. PubMed ID: 14107358
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chromogenic mycobacteria cultures from lesions of animal tuberculosis].
    Lafont J; Lafont P
    Zentralbl Bakteriol Orig; 1970; 215(2):225-33. PubMed ID: 4992025
    [No Abstract]   [Full Text] [Related]  

  • 10. [EXPERIMENTAL TUBERCULOSIS IN RATS].
    JANOWIEC M; VENULET J
    Gruzlica (1926); 1963 Jun; 31():712-6. PubMed ID: 14119459
    [No Abstract]   [Full Text] [Related]  

  • 11. [COMPARISON OF BCG VACCINES PRODUCED IN POLAND WITH BCG VACCINES PREPARED FROM BCG SUBSTRAINS OF VARIOUS ORIGINS].
    BURACZEWSKA M; KURYLOWICZ W; PAKLERSKA-POBRATYN H
    Gruzlica (1926); 1964 Sep; 32():781-8. PubMed ID: 14249995
    [No Abstract]   [Full Text] [Related]  

  • 12. PATHOGENICITY OF ATTENUATED AND AVIRULENT TUBERCLE BACILLI: THEIR IMPLICATION AS VACCINATING AGENTS IN HUMANS.
    STEENKEN W; RALEIGH JW; SMITH MM
    J Lancet; 1964 Mar; 84():85-8. PubMed ID: 14130128
    [No Abstract]   [Full Text] [Related]  

  • 13. [VIRULENT MUTANTS OF BCG CULTURES: BIOLOGICAL SELECTION AND PATHOGENICITY].
    LOPEZVALLEJO J
    Medicina (Mex); 1964 Oct; 44():472-7 CONCL. PubMed ID: 14214578
    [No Abstract]   [Full Text] [Related]  

  • 14. [LABORATORY STUDIES ON BCG VACCINE RESISTANT TO STREPTOMYCIN AND ISONIAZID ACTIVITY].
    BURACZEWSKA M; KURYLOWICZ W; PAKLERSKA-POBRATYN H
    Gruzlica (1926); 1964 Sep; 32():763-72. PubMed ID: 14249993
    [No Abstract]   [Full Text] [Related]  

  • 15. [COMPARISON OF CULTURE AND BIOCHEMICAL METHODS FOR THE DIFFERENTIATION OF MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM BOVIS WITH SPECIAL REFERENCE TO STRAINS WITH HIGH ISONIAZID RESISTANCE].
    STOTTMEIER D; ATAY N
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1964 Apr; 128():166-77. PubMed ID: 14212963
    [No Abstract]   [Full Text] [Related]  

  • 16. DISSOCIANTS OF M. TUBERCULOSIS AND ATYPICAL MYCOBACTERIA.
    REIMANN HA; MA PP
    Am Rev Respir Dis; 1965 Aug; 92():193-209. PubMed ID: 14340859
    [No Abstract]   [Full Text] [Related]  

  • 17. [Virulence of isoniazid-resistant strains of Mycobacterium tuberculosis for guinea pigs, rabbits, mice, and hamsters; modifications of bacterial metabolism].
    GERNEZ-RIEUX C; TACQUET A; HOUCKE E; FABRE M; GERARD A; VOISIN C
    Ann Inst Pasteur Lille; 1953-1954; 6():1-35. PubMed ID: 13268925
    [No Abstract]   [Full Text] [Related]  

  • 18. COMPARATIVE STUDIES ON BCG SUBSTRAINS OF VARIOUS ORIGIN. OBSERVATIONS ON THE STREPTOMYCIN AND ISONICOTINIC ACID HYDRAZIDE-SENSITIVE AND RESISTANT VARIANTS OF THE BRAZILIAN MOREAU SUBSTRAIN.
    KURYLOWICZ W; BURACZEWSKA M; KOSTRZENSKI W; KULEJEWSKA M; MANOWSKA W; MERKEL M; PICHULA K; PAKLERSKA POBRATYN H; TUSZYNSKA B
    Arch Immunol Ther Exp (Warsz); 1964; 12():182-95. PubMed ID: 14166658
    [No Abstract]   [Full Text] [Related]  

  • 19. [Various experimental diseases induced in guinea pigs by the historical Institut Pasteur BCG strain and by the B-1 positive catalase strain. Study of the viability of the inoculated bacteria].
    Levaditi JC; Kosloff-Sénéchal F; Balouet G; Augier J
    Ann Inst Pasteur (Paris); 1968 Dec; 115(6):1053-62. PubMed ID: 4890580
    [No Abstract]   [Full Text] [Related]  

  • 20. [PRIMARY BACTERIAL RESISTANCE].
    IANELLO JA
    Torax; 1963; 12():154-6. PubMed ID: 14158176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.